- Frequency Exchange (TSXV:FREQ), a health technology stock focused on light-emitted frequency treatments, is announcing that NHL star, Hockey Hall of Fame inductee and president of the Boston Bruins Cam Neely will join its advisory board
- Neely played for the Vancouver Canucks and Boston Bruins from 1983 to 1996
- Frequency Exchange develops and commercializes its NIKKI wellness technology, which offers treatments build around light-emitted frequencies for Lyme disease, sleep, pain, energy and immunity
- Frequency Exchange stock is down by over 50 per cent since inception in 2022
Frequency Exchange (TSXV:FREQ), a health technology stock focused on light-emitted frequency treatments, is announcing that NHL star, Hockey Hall of Fame inductee and president of the Boston Bruins Cam Neely will join its advisory board.
Neely was a power forward for the Vancouver Canucks and Boston Bruins from 1983 to 1996. He was granted entry into the Hockey Hall of Fame in 2005 and took on the role of vice president of the Boston Bruins in 2007, transitioning to president in 2010.
Neely is also president of the Cam Neely Foundation, a non-profit organization supporting cancer research and treatment, while providing accommodation, community and support to cancer patients and their families during treatment.
His previous board experience includes serving as a director at Whistler Blackcomb Holdings, the holding company for Whistler Blackcomb Ski Resort, before Vail Resorts acquired it in 2016.
Leadership insights
“I’m looking forward to joining the advisory board of Frequency Exchange and to working with their team to help more people discover the health benefits that frequency therapy can deliver,” Neely said in a statement. “I was first introduced to the company’s Wellness technology in 2016 and I have seen firsthand how this ground-breaking wearable device has helped my family manage and overcome the symptoms of Lyme disease. I believe the NIKKI wellness technology has a place in the world of sports and I would highly recommend NIKKI to anyone who wants to improve their personal wellbeing.”
“We are honoured to welcome Mr. Neely to our advisory board – he is an exemplary athlete who has excelled far beyond his career as a professional hockey player to prove to be a highly successful business leader,” added Stephen Davis, Frequency Exchange’s founder and chief executive officer. “Mr. Neely will play a strategic advisory role as the company prepares to sell its NIKKI wellness technology through new sales channels in the United States and Canada.”
About Frequency Exchange
British Columbia-based Frequency Exchange develops and commercializes its NIKKI wellness technology, which offers treatments build around light-emitted frequencies to help with Lyme disease, sleep, pain, energy and immunity, among others. The treatments are thought to restore and improve communication across the trillions of cells in the human body and have been shown to offer substantial benefits in third-party testing.
Frequency Exchange stock (TSXV:FREQ) opened with a loss of 2.86 per cent trading at C$0.17 per share. The stock is down by over 50 per cent since inception in 2022.
Join the discussion: Find out what everybody’s saying about this health technology stock on the Frequency Exchange Corp. Bullboard and check out the rest of Stockhouse’s stock forums and message boards.
The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
(Top photo of the NIKKI wellness device: Frequency Exchange)